Corbus Pharmaceuticals Holdings, Inc. 0SZI.L
0SZI.L
Corbus Pharmaceuticals Holdings, Inc. 0H8T.L
Aclaris Therapeutics, Inc. 0T6G.L
Q32 Bio Inc. 0J4V.L
Heron Therapeutics, Inc. 0R1D.L
Sangamo Therapeutics, Inc. 0KF3.L
Palatin Technologies, Inc. 0H7R.L
Abeona Therapeutics Inc. 0HIY.L
Atara Biotherapeutics, Inc. 0KCC.L
Insight Molecular Diagnostics Inc. 0IL8.L
FibroGen, Inc.
Corbus Pharmaceuticals Holdings, Inc. 0H8T.L
Aclaris Therapeutics, Inc. 0T6G.L
Q32 Bio Inc. 0J4V.L
Heron Therapeutics, Inc. 0R1D.L
Sangamo Therapeutics, Inc. 0KF3.L
Palatin Technologies, Inc. 0H7R.L
Abeona Therapeutics Inc. 0HIY.L
Atara Biotherapeutics, Inc. 0KCC.L
Insight Molecular Diagnostics Inc. 0IL8.L
FibroGen, Inc.
Performance
| Periode | 0SZI.L | 0H8T.L | 0T6G.L | 0J4V.L | 0R1D.L | 0KF3.L | 0H7R.L | 0HIY.L | 0KCC.L | 0IL8.L |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 175.95 % | 62.33 % | 80.40 % | -29.23 % | -3.75 % | -29.19 % | 19.93 % | 176.75 % | 35.23 % | 45.47 % |
| YTD | 31.93 % | -25.87 % | 3.31 % | -20.55 % | -35.46 % | -85.98 % | -7.61 % | 3.73 % | 64.50 % | -19.96 % |
| 1Y | -15.96 % | 55.62 % | -92.41 % | -26.84 % | -25.96 % | -81.36 % | -15.50 % | 85.64 % | 25.41 % | 21.90 % |
| 3Y | 330.50 % | -88.54 % | -86.38 % | -63.91 % | -85.40 % | -96.86 % | -4.65 % | -83.64 % | -75.00 % | -97.20 % |
| 5Y | -49.37 % | -73.37 % | -98.17 % | -93.85 % | -88.65 % | -99.07 % | -86.63 % | -42.35 % | 37.68 % | -97.14 % |
| 10Y | -91.55 % | -92.32 % | -99.09 % | -94.67 % | -88.65 % | -99.27 % | -98.61 % | -33.63 % | 1 776.54 % | -97.14 % |
| Depuis le début | -91.55 % | -92.32 % | -99.09 % | -94.67 % | -88.65 % | -99.27 % | -98.61 % | -33.63 % | 1 776.54 % | -97.14 % |